pd 131628 has been researched along with carbostyril in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagelbäck, A; Nord, CE | 1 |
| Lewin, CS | 1 |
| Andrews, JM; Cooper, MA; Wise, R | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Citron, DM; Goldstein, EJ | 1 |
| Jabarit-Aldighieri, N; Raoult, D; Torres, H | 1 |
| Forstall, GJ; Knapp, CC; Washington, JA | 1 |
| Bauernfeind, A | 1 |
| Allen, SD; Barry, AL; Fuchs, PC; Jorgensen, JH; Sewell, DL; Tenover, F | 1 |
| Finegold, SM; Molitoris, E; Reeves, D; Wexler, HM | 1 |
| Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
| Baltch, AL; Ford, AS; Ritz, W; Smith, RP | 1 |
| Allen, SD; Barry, AL; Citron, DM; Fuchs, PC; Wexler, HM | 1 |
| Allen, SD; Barry, AL; Fuchs, PC; Murray, PR; Sewell, DL; Tenover, FC | 1 |
| Cohen, MA; Huband, MD | 1 |
15 other study(ies) available for pd 131628 and carbostyril
| Article | Year |
|---|---|
Susceptibility of anaerobic bacteria to PD 131628.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacteroides fragilis; Clostridioides difficile; Clostridium perfringens; Fluoroquinolones; Fusobacterium; Microbial Sensitivity Tests; Naphthyridines; Propionibacterium acnes; Quinolones | 1992 |
Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628.
Topics: Anti-Infective Agents; Bacteria; DNA Repair; DNA, Bacterial; Enterococcus faecalis; Escherichia coli; Fluoroquinolones; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Quinolones; SOS Response, Genetics; Staphylococcus aureus; Staphylococcus epidermidis | 1992 |
In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
Topics: Anti-Infective Agents; Bacteroides fragilis; Ceftazidime; Cefuroxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gentamicins; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Imipenem; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Neisseria; Protein Binding; Quinolones | 1992 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones | 1992 |
Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Coxiella burnetii; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin; Quinolones; Rickettsia; Rickettsia rickettsii; Viral Plaque Assay | 1992 |
Activity of new quinolones against ciprofloxacin-resistant staphylococci.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus | 1991 |
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1993 |
Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628).
Topics: Anti-Infective Agents; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Naphthyridines; Piperazines; Quality Control; Quinolones | 1995 |
In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Culture Media; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1994 |
Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Xanthomonas | 1994 |
In-vitro susceptibilities of Pseudomonas aeruginosa and Pseudomonas spp. to the new fluoroquinolones clinafloxacin and PD 131628 and nine other antimicrobial agents.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Naphthyridines; Pseudomonas; Pseudomonas aeruginosa; Quinolones; Xanthomonas | 1993 |
Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1993 |
Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116)).
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Neisseria gonorrhoeae; Piperazines; Quality Control; Quinolones | 1996 |
In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Erythromycin; Fluoroquinolones; In Vitro Techniques; Microbial Sensitivity Tests; Mycoplasma hominis; Mycoplasma pneumoniae; Naphthyridines; Quinolones; Tetracycline; Ureaplasma urealyticum | 1997 |